The U.S. FDA has cleared Aroa Biosurgery Ltd.’s 510(k) for its Enivo pump and catheter, which are key components of the company’s new Enivo tissue apposition platform. The device applies negative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback